However, most published studies in this field lack discrimination between neovascular and non-neovascular AMD or were performed before the anti-VEGF era [5], and it has already been mentioned that anti-VEGF treatment yields an important improvement in the QoL of nAMD patients [3]. Here, VEGFA is linked to age-related macular degeneration.